Neurofibromatosis type 1: Difference between revisions
MoisesRomo (talk | contribs) |
MoisesRomo (talk | contribs) No edit summary |
||
Line 3: | Line 3: | ||
'''For patient information, click [[Neurofibromatosis type 1 (patient information)|here]]''' | '''For patient information, click [[Neurofibromatosis type 1 (patient information)|here]]''' | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}}[[User:MoisesRomo|Moises Romo, M.D.]] | ||
{{SK}} | {{SK}}[[neurofibromatosis type 1]], [[NF1|NF1 gene]], [[neurofibroma]], [[prevalence]], [[incidence]] | ||
==[[Neurofibromatosis type 1 overview|Overview]]== | ==[[Neurofibromatosis type 1 overview|Overview]]== |
Revision as of 23:59, 23 June 2020
Neurofibromatosis type 1 Microchapters |
Differentiating Neurofibromatosis type 1 from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Neurofibromatosis type 1 On the Web |
American Roentgen Ray Society Images of Neurofibromatosis type 1 |
Risk calculators and risk factors for Neurofibromatosis type 1 |
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Moises Romo, M.D.
Synonyms and keywords:neurofibromatosis type 1, NF1 gene, neurofibroma, prevalence, incidence
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating neurofibromatosis type 1 from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic study of choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X-Ray Findings | Echocardiography and Ultrasound | CT-Scan Findings | MRI Findings | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Interventions | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies